CovidVax show full list
COVID-19 VACCINE:

Whole - Virion Inactivated (COVAXIN) - BBV152

researcher:
Bharat Biotech + Ocugen Inc. + Precisa Medicamentos
https://www.bharatbiotech.com/index.html
(India)
vaccine type: Inactivated virus

distribution (started in January 2021):
Central African Republic, Comoros, India, Iran, Mauritius, Pakistan, Paraguay
Distribution updates
Jan 03DCGI-CDSCO granted BBV152 permission for emergency use in India (by bharatbiotech.com)
Human Testing updates (clinical trials)

PHASE 1-2

 

started July 13 2020

with 1125 healthy people aged 12-65

trial location: India

» clinical trial details

PHASE 1-2

 

started September 8 2020

with 124 healthy people aged 12-65

trial location: India

» clinical trial details

PHASE 3

 

started November 25 2020

with 25800 healthy volunteers aged 18+

trial location: India

» clinical trial details

Mar 03Bharat Biotech announced the first interim analysis of its BBV152 showing that the vaccine was well tollerated in a group of 25800 subjects (by bharatbiotech.com)
Dec 23BBV152 showed long-term antibodies in Phase 1 volunteers and tolerable safety outcomes in the Phase 2 study (by bharatbiotech.com)
Dec 16COVAXIN demonstrated acceptable safety profile and high immune response which induced T-cell responses in Phase 1 study (by researchsquare.com)
Dec 16In COVAXIN's Phase 1 placebo-controlled,double-blinded clinical trial 375 subjects were evaluated (by bharatbiotech.com)
Nov 26Covaxin began its Phase 3 human trial at AIIMS in New Delhi and will be given to around 15000 volunteers in the next few days (by livemint.com)
Nov 11Covaxin's third phase of clinical trials has started with AMU VC Professor Tariq Mansoor being the first volunteer for the trials (by livemint.com)
Sep 22Three Government Medical Colleges in Punjab will participate in COVAXIN's Phase 3 trials scheduled to begin Oct. 15 (by yahoo.com)
Sep 20COVAXIN's Phase 2 clinical trials began at PGI Rohtak on Wednesday with 50 volunteers (by republicworld.com)
Aug 19Bharat's Covaxin results of Phase 1/2 human trials are expected in India in a few weeks (by hindustantimes.com)
Jul 27Bharat's Covaxin vaccine showed encouraging results after Phase 1 human trials were completed (by deccanchronicle.com)
Animal Testing updates (pre-clinical trials)
Sep 11COVAXIN (BBV152) showed demonstration of protective efficacy and immunogenicity in non-human primates (by bharatbiotech.com)
Sep 10BBV152 demonstrated remarkable immunogenicity and protective efficacy in rhesus macaques (by researchsquare.com)
early development updates
currently no early development info



partnerships:
Feb 02Ocugen Inc and Bharat Biotech have entered into a definitive agreement to co-develop,supply and commercialize Bharat Biotech's vaccine (by bharatbiotech.com)
Jan 12Bharat Biotech announced that it has signed an agreement with Precisa Medicamentos for the supplies of COVAXIN in Brazil (by bharatbiotech.com)
Dec 22Ocugen Inc. and Bharat Biontech have signed a letter of intent to co-develop Bharat Biotech's COVID-19 vaccine (by globenewswire.com)



contact | about | ©2020 CovidVax.org project